Tempus Labs, Inc is a company that was started by Eric Lefkofsky. In 2021, his company was quite successful. His company raised 8.1 billion in revenue, which is very impressive for this type of business venture. With this new found success of Tempus, Eric Lefkofsky is looking at bigger sites. The company is reportedly looking to buy a new IPO to complement the medical side of Tempus Labs.
The details of this business venture is private, as the company is not giving the public much information. This is due to the fact that the timing of the company’s decisions can change at any time. In 2015, Tempus ONE stated that they company has created the largest library of clinical and molecular data. As Eric Lefkofsky states they use this information to help improve the quality of patient care.
Tempus is also considering adding an algorithm based laboratory developed test. Tempus, according to the official website , aims to transform cancer care by making personalized medicine accessible. Eric Lefkofksy points out that with all of this information that the Lab has been storing and analyzing, it does not come as a shocker to many that Tempus is in talks to acquire an IPO.
While the company has some competition out there in the Medical Based world, not many can come close to what the Team at Tempus Lab has done for the healthcare community. Tempus lab has a well qualified CEO and has also built a team of specialists to help them to put themselves on a level that no one else has touched before. For Eric Lefkofksy, the new business ventures help to make sure Tempus Labs is here to stay for the future.